Johnson Kate M, Safari Abdollah, Tan Wan C, Bourbeau Jean, FitzGerald J Mark, Sadatsafavi Mohsen, Study On Behalf Of The Canadian Cohort Of Obstructive Lung Disease CanCOLD
Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada,
Institute for Heart and Lung Health, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada,
Int J Chron Obstruct Pulmon Dis. 2018 Dec 13;13:3983-3995. doi: 10.2147/COPD.S184424. eCollection 2018.
The burden of symptoms varies markedly between patients with COPD and is only weakly correlated with lung function impairment. While heterogeneity in lung function decline and exacerbations have been previously studied, the extent of heterogeneity in symptoms and the factors associated with this heterogeneity are not well understood.
A sample of the general Canadian population ≥40 years with persistent airflow limitation was followed for up to 3 years. Participants reported whether they experienced chronic coughing, phlegm, wheezing, or dyspnea during visits at 18-month intervals. We used mixed-effect logistic regression models (separately for each symptom) to assess overall heterogeneity in the occurrence of symptoms between individuals, and the proportion of variation in symptom burden explained by lung function vs all other clinical characteristics of participants.
Four hundred forty-nine participants (53% male, mean age 67 years) contributed 968 visits in total, and 89% of patients reported at least one symptom during follow-up. There was substantial heterogeneity in the individual-specific probabilities for the occurrence of symptoms. This heterogeneity was highest for wheeze and dyspnea (IQR of probabilities: 0.13-0.78 and 0.19-0.81, respectively). FEV explained 28% of the variation between individuals in the occurrence of dyspnea, 8% for phlegm, 3% for cough, and 2% for wheeze. All clinical characteristics of participants (including FEV) explained between 26% of heterogeneity in the occurrence of cough to 49% for dyspnea.
There is marked heterogeneity in the burden of respiratory symptoms between COPD patients. The ability of lung function and other commonly measured clinical characteristics to explain this heterogeneity differs between symptoms.
慢性阻塞性肺疾病(COPD)患者的症状负担差异显著,且与肺功能损害仅存在微弱关联。虽然此前已对肺功能下降和急性加重的异质性进行了研究,但症状异质性的程度以及与此异质性相关的因素尚不清楚。
对年龄≥40岁、存在持续性气流受限的加拿大普通人群样本进行了长达3年的随访。参与者每隔18个月就诊时报告是否经历过慢性咳嗽、咳痰、喘息或呼吸困难。我们使用混合效应逻辑回归模型(针对每种症状分别进行分析)来评估个体间症状发生的总体异质性,以及肺功能与参与者所有其他临床特征对症状负担变异的解释比例。
449名参与者(53%为男性,平均年龄67岁)共进行了968次就诊,89%的患者在随访期间报告至少出现一种症状。症状发生的个体特异性概率存在显著异质性。喘息和呼吸困难的异质性最高(概率的四分位距分别为0.13 - 0.78和0.19 - 81)。第一秒用力呼气容积(FEV)解释了个体间呼吸困难发生变异的28%、咳痰变异的8%、咳嗽变异的3%以及喘息变异的2%。参与者的所有临床特征(包括FEV)解释了咳嗽发生异质性的26%至呼吸困难发生异质性49%。
COPD患者的呼吸道症状负担存在显著异质性。肺功能和其他常用测量的临床特征对这种异质性的解释能力因症状而异